PRESS RELEASE: SHOEBOX AUDIOMETRY ADDS CAPABILITIES FOR OUT OF BOOTH TESTING
Version 5.0 of iPad Audiometer adds Patent-pending REACT™ Technology, Assisted Mode Testing, and SRT/SDT Testing
Ottawa, ON, June 19, 2018 – Clearwater Clinical Limited, the leading manufacturer of iPad-based audiometers, announced today that it has released version 5.0 of its flagship product, SHOEBOX Audiometry. Version 5.0 is a major step forward in delivering on our core mission - to make hearing testing more accessible, easy, and accurate.
Today, Clearwater Clinical Limited announced that the company has received CE Mark approval for SHOEBOX Audiometry in Europe as an audiometer intended for diagnosis of human hearing loss. SHOEBOX is the world’s first CE Marked iPad-based audiometer. The device is also listed as a Class II medical device with US FDA and Health Canada.
OTTAWA, ONTARIO – April 6, 2017 – Clearwater Clinical Limited, a leading provider of medical-grade hearing health mobile devices and cloud-based data management solutions, is incorporating a simple screening tool into its product suite of mobile audiology devices with the launch of SHOEBOX QuickTest. This simple, self-administered hearing test is the ultimate companion to the Standard and Pro Editions of SHOEBOX Audiometry, which is the world’s first clinically-validated iPad audiometer.
OTTAWA, ONTARIO – February 28, 2017 – Clearwater Clinical Limited, a leading provider of medical-grade mobile devices and cloud-based data management solutions for the hearing health industry is expanding the testing capabilities of their SHOEBOX Audiometry product. With the addition of Extended High Frequency (EHF) testing, SHOEBOX Audiometry, the world’s first clinically-validated iPad audiometer, can now test ranges as high as 16 kHz.
OTTAWA, ONTARIO – January 12, 2017 – Clearwater Clinical Limited, a leading provider of medical-grade mobile devices and cloud-based data management solutions for the hearing health industry, today announced it has closed $6 million in Series A funding. The round was led by Whitecap Venture Partners, a Toronto-based early stage venture capital fund that invests in high growth companies in Information & Communications Technologies (ICT), Med Tech, and Food Tech. Whitecap Venture Partners will work closely with Clearwater Clinical on a number of strategic initiatives including product development, go to market programs, and future financing strategy. BDC Capital Healthcare Venture Fund is also participating significantly in the funding, and along with other investors brings the total capital invested in the company to date to $9.5 million.